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Heme oxygenase-1 (HO-1) is a
cytoprotective enzyme that controls
inflammation and redox homeostasis;
however, its role in tuberculosis (TB) is
unclear. Using freshly resected human
lung tissue and HO-1-deficient mice,
Chinta et al. demonstrate that HO-1 in
myeloid cells is important for controlling
inflammatory and free-radical-mediated
tissue damage in TB.
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Heme oxygenase-1 (HO-1) is a cytoprotective
enzyme that controls inflammatory responses and
redox homeostasis; however, its role during pulmo-
nary tuberculosis (TB) remains unclear. Using freshly
resected human TB lung tissue, we examined the
role of HO-1 within the cellular and pathological
spectrum of TB. Flow cytometry and histopatholog-
ical analysis of human TB lung tissues showed that
HO-1 is expressed primarily in myeloid cells and
that HO-1 levels in these cells were directly propor-
tional to cytoprotection. HO-1 mitigates TB patho-
physiology by diminishing myeloid cell-mediated
oxidative damage caused by reactive oxygen and/
or nitrogen intermediates, which control granulocytic
karyorrhexis to generate a zonal HO-1 response. Us-
ing whole-body or myeloid-specific HO-1-deficient
mice, we demonstrate that HO-1 is required to con-
trol myeloid cell infiltration and inflammation to pro-
tect against TB progression. Overall, this study
reveals that zonation of HO-1 in myeloid cells modu-
lates free-radical-mediated stress, which regulates
human TB immunopathology.
INTRODUCTION
Mycobacterium tuberculosis (Mtb), the etiological agent of tuber-
culosis (TB) disease, is a highly contagious pathogen that is1938 Cell Reports 25, 1938–1952, November 13, 2018 ª 2018 The A
This is an open access article under the CC BY license (http://creativespread via inhalation of infectious droplets released from the
lungs of infected individuals. While the disease is mostly asymp-
tomatic, active pulmonary TB, characterized by extensive
hemoptysis and extensive tissue damage, is often lethal. The for-
mation of caseous granulomas is a hallmark ofMtb infection that
involves accumulation of myeloid cells, including neutrophils,
macrophages, and myeloid-derived suppressor cells (MDSCs)
to infected sites (du Plessis et al., 2013; Obrego´n-Henao et al.,
2013; Silva Miranda et al., 2012). While the formation of granu-
lomas can be beneficial for the host, it may also serve as a
safe niche for the bacterium (Silva Miranda et al., 2012). In addi-
tion, the uncontrolled infiltration of myeloid cells and subsequent
inflammation, including reactive oxygen intermediates (ROIs)
and reactive nitrogen intermediates (RNIs), may contribute to
disease pathology (Chinta et al., 2016). However, most studies
on myeloid-mediated inflammation in TB have relied on animal
models or blood from TB patients. Assessing the clinical rele-
vance of these findings is difficult, because animal models and
ex vivo blood analysis have limitations in recapitulating human
disease (Dharmadhikari and Nardell, 2008). Further, the micro-
anatomic architecture of human pulmonary TB is mostly unex-
plored, largely due to the paucity of resected human tuberculous
lung tissue. Not surprisingly, correlating the immune state of the
patient and the clinicopathological manifestations of pulmonary
TB lesions has been difficult, as is evident by few reports dated
decades ago (Lenzini et al., 1977; Ridley and Ridley, 1987).
Heme oxygenase-1 (HO-1) is a redox-sensitive cytoprotective
enzyme that degrades heme, a potent oxidant, to yield equimolar
ratios of carbon monoxide (CO), iron, and bilirubin (Tenhunen
et al., 1968). HO-1 protects cells from heme-mediated oxidative
and nitrosative stress and injury and is involved in myeloid celluthor(s).
commons.org/licenses/by/4.0/).
recruitment and T cell responses in many pathological condi-
tions (Castilho et al., 2012; Choi and Alam, 1996; Freitas et al.,
2006; George et al., 2008). We and others have shown that
HO-1 is upregulated in response toMtb infection in mice and re-
sponds independently of the interferon-g (IFN-g)/nitric oxide
(NO) pathway and that HO-1-generated CO is required for the in-
duction of the Mtb Dos dormancy regulon (Kumar et al., 2008;
Shiloh et al., 2008). HO-1 is required to control Mycobacterium
avium and Mtb infections in mice (Regev et al., 2012; Silva-
Gomes et al., 2013). In addition, it was recently shown that the
free heme iron released by HO-1 enzymatic activity is bound
by ferritin H, which is required to control Mtb infection in mice
(Reddy et al., 2018). Also, HO-1 levels in the plasma of TB can
distinguish patients with active TB from latently infected individ-
uals (Andrade et al., 2013), as a readout for the efficacy of TB
therapy or diagnosis of TB-HIV co-infection (Rockwood et al.,
2017). Furthermore, HO-1 levels in plasma were reported to be
inversely correlated with the levels of matrix metalloproteinases,
which contribute to tissue destruction in TB (Andrade et al.,
2015; Salgame, 2011). More recently, studies have challenged
the beneficial role of HO-1 in TB disease, reporting that pharma-
cological inhibition of HO-1 in mice leads to a decrease in Mtb
burden (Costa et al., 2016; Scharn et al., 2016). These conflicting
findings, in addition to the fact that the essentiality of HO-1 in hu-
mans andmice varies significantly, represent a substantial gap in
our understanding of the role of HO-1 in TB.
In this study, we tested the hypothesis that HO-1 is essen-
tial for effective immune and oxidative stress control to limit
TB pathology in mice and human tuberculous lungs. To test
this hypothesis, we used multiparameter flow cytometry and
immunohistochemistry to examine HO-1 expression in freshly
resected and fixed lung tissues of TB patients. The spatial
distribution of HO-1 within the microenvironment of human pul-
monary TB lesions was also examined. Using global HO-1
knockout (HO-1/) and myeloid cell-specific HO-1 knockout
(HO-1LysM/) mice, we studied the survival, disease progres-
sion, transcriptional changes, and immune responses upon
Mtb infection. Overall, our data show that the expression of
HO-1, especially within myeloid cells, is essential for host de-
fense against TB disease.
RESULTS
Cellular Distribution of HO-1 within the
Histopathological Spectrum of TB
Historically, clinical and immunological studies have attempted
to define the clinicopathological manifestations of TB disease
and relate them to the immune state of TB patients. However,
a correlation between the immune state and the pathological
spectrum is lacking (Barry et al., 2009; Ridley and Ridley,
1987). To determine the role of HO-1 within the pathological
spectrum of TB, we examined the microanatomic distribution
of HO-1 within human TB lungs. Pathologic features were
appraised in terms of necrotizing (cavity wall, tubercle), non-
necrotizing granulomas, and control lung sections.
Cavity Wall
Microscopically, the lumen contained erythrocytes, an adluminal
exudative component composed mainly of neutrophils, nucleardebris, and giant cells, including phagocytic giant cells (Figures
S1A and S1B). Fibrinoid necrosis was noted, in addition to a
confluent granulomatous layer composed mainly of epithelioid
histiocytes, some of which demonstrated palisading and outer-
most inflamed granulation tissue (Figure S1B). HO-1 staining of
different cavity wall components was variable (Figure S2A).
HO-1 staining was bright in giant cells (Figure 1, inset i), the gran-
ulomatous inflammatory component, and endothelial cells in all
layers, but it was especially bright in the granulation tissue (Fig-
ure 1). Negative controls using a secondary antibody alone
(Figures S2B and S2C) or an isotype control antibody (Figures
S2D–S2G) showed immunonegative reactions, demonstrating
the specificity of HO-1 staining. Intact neutrophils, lymphocytes,
histiocytes, and plasma cells stained brightly for HO-1 (Figure 1,
inset ii). However, karyorrhectic (leukocytoclastic) neutrophils
and nuclear debris were unstained (Figure 1, inset iii). Karyor-
rhexis is a histomorphological, usually diagnostic feature present
in a variety of diseases, including infective (bacillary angiomato-
sis) (Laga and Milner, 2015) and non-infective sources (Barks-
dale et al., 2015) (e.g., Wegener granulomatosis, erythema
elevatum diutinum, granuloma faciale, small-vessel neutro-
philic and/or leucocytoclastic vasculitis, and cryoglobulinemia).
Further evidence supporting karyorrhexis was obtained through
histomorphology and histochemical features in the adluminal
suppurative and/or karyorrhectic zone in TB lung tissue (Fig-
ure S3A). Positive controls include an abscess highlighting
intact neutrophils and nuclear karyorrhectic debris (Fig-
ure S3B) and a Sweet syndrome section (neutrophil dermatosis)
showing a dense cellular dermal infiltrate of intact neutrophils
and neutrophil karyorrhexis (Figure S3C). Both controls show
clear histomorphological features consistent with karyorrhexis
in TB lung tissue. Lastly, to address the relationship between
karyorrhexis and dying cells histologically, we performed
chloroacetate esterase (CAE) staining routinely used for identifi-
cation of neutrophil degeneration and hematologic disorders.
This method of identifying neutrophil degeneration in tissue
sections is highlighted by degranulation and the loss of
chloroacetate-esterase-stained (rose-pink) cytoplasmic gran-
ules (Figure S3D).
Tubercles
Tubercles were identified at low magnification by the central ne-
crosis (Figures S4A and S4B). Higher magnification revealed that
the central necrotic region was surrounded by a fibro-inflamma-
tory and granulomatous region (Figure S4B). Within the micro-
anatomic components of the tubercles, some neutrophils in
the caseative component, giant cells, and histiocytes in granu-
lomas and endothelial cells in the outer vascularized fibrous
lamellae demonstrated high levels of HO-1 protein (Figures
2A–2D). The granular caseative debris was HO-1 negative
(Figure 2B).
Non-necrotizing Granulomatous Inflammation
The granulomas that were variably aggregated had an organized
morphology and were composed of Langhans giant cells, histio-
cytes, and lymphocytes (Figure S4C). HO-1 staining in the gran-
ulomas within the non-necrotizing granulomatous inflammation
(NNGI) foci was similar to that in the tubercles and cavity wall
(Figures 2C and 2D). A morphometric appraisal of necrotic and
NNGI lesions demonstrated striking differences in the spatialCell Reports 25, 1938–1952, November 13, 2018 1939
Figure 1. HO-1 Staining Profile in the Cavity Wall
HO-1 staining of cellular component in adluminal cells with bright staining of phagocytic giant cells (arrowheads, inset i), bright staining of neutrophils (arrows,
inset ii), and negative karyorrhectic neutrophil staining (rectangle, inset iii) (L = Lumen). Shown is bright staining of histiocytes in the granulomatous layer (black
asterisks) and bright staining of inflammatory cells (lymphocytes, plasma cells, and histiocytes) and endothelial cells (yellow arrows) in the granulation tissue layer
(asterisk).distribution of HO-1. In necrotic lesions, HO-1 levels were signif-
icantly reduced, whereas in NNGI lesions, HO-1 levels increased
(Figures S4D and S4E). Healthy lung control sections demon-
strated normal alveolar spaces, septa, and vascular and bron-
chiolar components (Figure S4F). In the control sections, the
aerated compartments, including pneumocytes and intra-alve-
olar histiocytes, were strongly HO-1 positive. In addition, cells
in oxygen-rich tissue such as endothelial cells within capillaries
and circulating cells also expressed high levels of HO-1. Scat-
tered intra-alveolar histiocytes were present. HO-1 staining1940 Cell Reports 25, 1938–1952, November 13, 2018was observed in pneumocytes, endothelial cells in the interstitial
vessels, focal intra-alveolar histiocytes, and circulating intravas-
cular neutrophils (Figure S4F, inset).
In summary, the histopathological appraisal of TB lung speci-
mens revealed a defined spectrum of microscopic abnormal-
ities, including hemorrhage. The spatial distribution of HO-1 in
different tuberculous lesions reflects different architectural and
cellular patterned responses. Notably, while Langhans giant
cells, histiocytes, plasma cells, and endothelial cells in themicro-
anatomic locations stained positively for HO-1, karyorrhectic
(legend on next page)
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neutrophils consistently showed markedly reduced HO-1 levels,
particularly in cavities and near necrotic granulomatous foci.
Notably, the cell-type-specific expression of HO-1 within
discrete microanatomical locations, which generates a zonal
distribution, together with the essential role HO-1 plays in human
health, provides evidence for a central role of HO-1 in the path-
ophysiology of TB.
Arg-1, Nrf2, iNOS, and Neutrophil Levels in the Lungs of
TB Patients
Immunohistochemical (IHC) analysis revealed that expression
of Nrf2, a major transactivator of HO-1 promoter activity, was
increased in human TB lungs compared to non-TB controls (Fig-
ure S5). Considering HO-1 downstream signaling is known to
modulate expression of Arginase-1 (Arg-1) and inducible nitric ox-
ide synthase (iNOS) (Bolisetty et al., 2015; Datta et al., 1999), we
used IHCtomaptheseproteins inhuman lung tissue.Weobserved
increasedArg-1 staining in TBdiseased tissue,which is consistent
with other studies (Duque-Correa et al., 2014), but found no
measurable differences in iNOS levels between TB diseased and
control tissues (Figure S5). No staining was observed in isotype
control images. Overall, our results demonstrate that Nrf2, iNOS,
and Arg-1 are produced at the site of infection, suggesting a role
for them in human TB. Histopathological examination revealed
extensive karyorrhexis, an oxidative-stress-induced degenerative
process that releases DNA. Therefore, we examined whether
neutrophil extracellular traps (NETs) are formed in humanTB lungs
using standardmarkers neutrophil elastase (NE) andmyeloperox-
idase (MPO). Indeed, significant accumulation of neutrophils in
humanTB lung tissuewasobserved (FigureS6A), but not in control
lung (Figure S6B). Positive histone H2A staining near NE- and
MPO-positive neutrophils strongly suggest the formation of
NETs in the human tuberculous lung.
HO-1 Levels in Myeloid Cells from Pathologically
Distinct Regions of Human TB Lungs
Distinct immune cell populations in the blood, pleural cavity fluid,
and bronchoalveolar lavage fluid (BALF) of TB patients have
been described. However, to the best of our knowledge, there
has been no detailed flow cytometric characterization of immune
cell populations within the human TB lung. Here we examined
the cellular distribution of HO-1 in freshly resected lung tissue
from 21 TB patients (Table S1). A representative chest radio-
graph of a patient with advanced TB prior to pneumonectomy
demonstrates a shrunken right lung with a large cavity in the
upper lobe, which was then confirmed by a high-resolution CT
scan (Figure S6C). The post-pneumonectomy chest radiograph
is also shown. The resected lung exhibited distinct regions
with varying disease severity that include highly diseased (Dis),
intermediate disease (Int), and uninvolved (Uni) areas withFigure 2. HO-1 Staining of Tubercles and Non-necrotizing Granulomas
(A and B) Low-power magnification of HO-1 staining in lung parenchyma with
scattered neutrophils (arrows) in the central caseative component (B). Also show
and epithelioid histiocytes in granulomas (arrowheads) and HO-1-positive endot
(C and D) Bright HO-1 staining of granulomas (rectangle) at medium (C) and high m
black arrowheads) were strongly HO-1 positive. HO-1-positive endothelial cells
shown.
1942 Cell Reports 25, 1938–1952, November 13, 2018normal lung architecture (Figure S6D). As reported in cancer pa-
tients (Sellers et al., 2015), examination of lung tissues with vary-
ing disease severity from the same patient eliminates potentially
confounding intrinsic genetic variables and is optimal for analysis
of host responses during TB disease progression.
CD45+ leukocytes were isolated from pathologically distinct
regions (diseased, intermediate, and uninvolved) within human
TB lungs. From these CD45+ populations, we sorted neutrophils
(CD11b+CD66b+CD16+CD14CD3), macrophages (HLADR+
CD11c+CD206+CD11b+CD86+CD16CD66bCD3), mono-
cytes (CD14+HLA-DR+CD11clowCD66bCD3), and T cells
(CD3+CD14CD11b) and determined the intracellular HO-1
levels in these cell types (Figure 3A). Neutrophils and macro-
phages were the predominant HO-1-producing cell types.
Surprisingly, the percentages of HO-1-producing neutrophils,
macrophages, and monocytes isolated from diseased regions
were significantly reduced compared to cells isolated from unin-
volved regions (Figures 3B–3J). More importantly, we observed
that the mean fluorescent intensity (MFI) of HO-1 immunostain-
ing was reduced in neutrophils, macrophages, and monocytes
isolated from diseased lung regions compared to intermediate
and healthy uninvolved regions (Figures 3B–3J). T cells pro-
duced very low or no HO-1 (data not shown). Interestingly, a
comparison of the relative HO-1 levels within the same four cell
populations isolated from the blood of TB patients showed that
compared to healthy individuals, HO-1 levels are reduced in
circulating neutrophils of TB patients (Figures S6E and S6F).
HO-1 was low or undetectable in all other leukocyte types iso-
lated from the blood (data not shown), suggesting that the im-
mune cell composition of the blood may not accurately reflect
the microenvironment of the human tuberculous lung.
Overall, we show that macrophages and neutrophils are the
predominant HO-1-producing immune cells in the human TB
lung and that reduced HO-1 levels in these cells correspond
with increased disease severity. The flow cytometry findings
are consistent with our histopathological data showing that the
most diseased foci (cavitary and necrotic granulomatous lesions)
contain karyorrhectic neutrophils with reduced HO-1 staining.
Myeloid Cells with Decreased HO-1 Exhibit Increased
ROS and Reactive Nitrogen Species Production
Given that HO-1 has potent antioxidant activity, reduced levels
of HO-1 in cavitary, coagulative, and necrotic granulomatous
foci of human TB lungs indicate that these regions may be
exposed to high levels of oxidative stress. Therefore, we
measured ROIs and RNIs in the same immune cell isolates in
which we measured HO-1 production. Using the superoxide
(O2
C)-reactive dye dihydroethidium (DHE), we observed
significant increases in the percentages of reactive oxygen spe-
cies (ROS)-positive neutrophils, macrophages, and monocytesmultiple tubercles (T) (A) and high-power demonstration of HO-1 positivity in
n are HO-1-negative granular debris (square, inset), HO-1-positive giant cells,
helial cells lining capillaries in fibrous lamellae (oval).
agnification (D). Langhans giant cells (D, arrows) and epithelioid histiocytes (D,
(yellow arrowheads) in the adjacent vasculature and myofibroblasts (oval) are
Figure 3. HO-1, ROS, and RNS Levels in Myeloid Cells Isolated from Severely Diseased Regions of Human Tuberculous Lung Tissue
(A) The sequential flow cytometry gating strategy for identification of monocytes, macrophages, neutrophils, and T cells from freshly isolated CD45+ cells within the
distinct pathological regions of human TB lung. Cells were identified by the following cell-surface markers: monocytes (CD14+HLA-DR+CD11clowCD66bCD3),
macrophages (HLA-DR+CD11c+CD206+CD11b+CD86+CD16CD66bCD3), neutrophils (CD11b+CD66b+CD16+CD14CD3), andTcells (CD3+CD14CD11b).
(B) Representative histogram of HO-1 expression in neutrophils.
(C and D) Percentage of HO-1+ neutrophils (C) and MFI of HO-1 in neutrophils (D).
(E) Representative histogram of HO-1 expression in macrophages.
(F and G) Percentage of HO-1+ macrophages (F) and MFI of HO-1 in macrophages (G).
(H) Representative histogram of HO-1 expression in monocytes.
(I and J) Percentage of HO-1+ monocytes (I) and MFI of HO-1 in monocytes (J).
(K and L) Percentage of ROS-positive neutrophils, macrophages, and monocytes (K) and their respective MFI of ROS (L).
(M and N) Percentage of RNS-positive neutrophils, macrophages, and monocytes (M) and their respective MFI within isolated lung immune cells (N).
n = 9–12 individual patients per group (each dot represents an individual patient). Statistical testing was performed using the unpaired Student’s t test. Data are
presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. Black curve in (B), (E), and (H) represents isotype control (Iso).
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Figure 4. HO-1/ Mice Are More Susceptible to Mtb Infection
(A) Kaplan-Meier survival analysis of HO-1+/+ and HO-1/mice following infection withMtbH37Rv. Uninfected HO-1+/+ and HO-1/micewere used as controls
and survived the duration of the study (data not shown). n = 10 mice per group.
(B and C) Mtb bacillary burden in lungs (B) and spleens (C) of HO-1+/+ and HO-1/ mice at 6, 12, and 18 weeks post-infection.
(D) H&E staining of representative lung and spleen sections from Mtb-infected HO-1+/+ and HO-1/ mice at 18 weeks post-infection.
(E) Trichrome staining of representative lung and spleen sections fromMtb-infected HO-1+/+ and HO-1/mice at 18 weeks post-infection. Blue (as indicated by
arrows) shows collagen deposition (scale bar, 100 mm).
(F) Western blot analysis of HO-1 and Nrf-2 in the total lung protein extract of uninfected andMtb-infected HO-1+/+ and HO-1/mice at 6, 12, 18, and 40 weeks
post-infection. Each lane represents individual mice.
(G and H) Quantification of HO-1 (G) and Nrf-2 (H) western blots shown in (F) using ImageJ software. Target genes were normalized against the housekeeping
gene GAPDH.
(I) Relative HO-1 mRNA expression in the lungs of Mtb-infected HO-1+/+ mice was determined using qRT-PCR, normalized to the housekeeping gene b-actin.
n = 4 for each time point. Statistical testing was performed using the unpaired Student’s t test. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01,
***p < 0.001.isolated from severely diseased tissue compared to uninvolved
lung (Figure 3K). We also observed a corresponding increase
in the MFI of DHE fluorescence in these myeloid cell types (Fig-
ure 3L). Further, using the NO-reactive dye 4-amino-5-methyla-
mino-20,70-difluorofluorescein (DAF-FM) diacetate, we detected
significant increases in the percentages of reactive nitrogen spe-
cies (RNS)-positive macrophages and monocytes isolated from
severely diseased tissue compared to uninvolved tissue (Fig-
ure 3M). Interestingly, while there was no difference in the per-
centages of RNS-positive neutrophils based on tissue disease
severity (Figure 3M), there was a significant increase in the cor-
respondingMFI of DAF-FM in all threemyeloid cell types isolated1944 Cell Reports 25, 1938–1952, November 13, 2018from diseased tissue (Figure 3N). Taken together, these data
suggest that reduced levels of HO-1 and increased levels of
ROS and RNS in myeloid cells are important contributors to TB
immunopathology.
HO-1/ Mice Are More Susceptible to Mtb Infection
To investigate the role of HO-1 in TB disease progression and
survival, we infected wild-type (HO-1+/+) mice and mice
completely deficient in HO-1 expression (HO-1/). HO-1/
mice were more susceptible to Mtb infection and began to suc-
cumb by 102 days post-infection, with a median survival of
204 days compared to 267 days for HO-1+/+ mice (Figure 4A).
As expected, the bacillary load in the lungs (Figure 4B) and
spleens (Figure 4C) was significantly higher in HO-1/ mice
than HO-1+/+ mice at 12 and 18 weeks post-infection. The
increased bacillary burden in HO-1/ mice was accompanied
by severe disease pathology (Figure 4D) and fibrosis (Figure 4E)
at 18 weeks post-infection.
Our findings in human TB lungs showed that reduced HO-1
levels are associated with increased disease. Therefore, we
tested whether HO-1 mRNA or protein levels change in the
lung during Mtb infection in mice. In HO-1+/+ mice, HO-1
mRNA (Figure 4I) and protein levels (Figures 4F and 4G) were
increased at 6 weeks post-infection and continued to increase
for at least 18 weeks. However, at a much later stage of the dis-
ease (40 weeks), HO-1 mRNA and protein levels were drasti-
cally reduced. To determine whether reduced levels of HO-1
at the late stage of infection were a consequence of changes
in Nrf2, a master transcriptional regulator of oxidative-stress-
related enzymes, we monitored Nrf2 levels over 40 weeks of
infection. Mtb infection modestly increased Nrf2 protein levels
in HO-1+/+ mice at 18 weeks, which correlated with increases
in HO-1 expression. However, at 40 weeks post-infection,
Nrf2 levels remained elevated (Figures 4F and 4H) in contrast
to HO-1 levels. Nrf2 levels were not markedly different between
HO-1/ and wild-type (WT) mice. Taken together, the data
demonstrate that HO-1 expression is temporal and is neces-
sary for host protection against Mtb disease. Also, reduced
levels of HO-1 in mice correlate with increased disease
severity. These findings are consistent with our human
data and substantiate the importance of maintaining homeo-
static levels of HO-1 in host protection against TB disease
progression.
Myeloid Cell Infiltration Is Dysregulated inMtb-Infected
HO-1/ Mice
Since whole-blood transcriptome profiling has been proposed
as a reliable measure of immune responses in TB patients
(Berry et al., 2010), and because the plasma levels of HO-1
have been suggested as a potential TB diagnostic marker (An-
drade et al., 2013; Andrade et al., 2014), we generated global
transcriptomic profiles of blood monocytes from Mtb-infected
mice. We identified 264 differentially regulated genes in Mtb-in-
fected HO-1/ mice (234 upregulated and 30 downregulated;
Table S2). Using Ingenuity Pathway Analysis (IPA), we identified
the top ten differentially regulated pathways in the categories of
‘‘immune cell trafficking’’ (Figure S7A) and ‘‘inflammatory re-
sponses’’ (Figure S7B) in HO-1/ mice. The majority of these
pathways control the movement, infiltration, and chemotaxis
of different myeloid cell subsets, in particular neutrophils. Within
these pathways, major pro-inflammatory genes such as SOCS-3
and interleukin-12b (IL-12b) were significantly upregulated
whereas IFN-g was significantly downregulated in Mtb-infected
HO-1/ mice (Figure S7C).
Next, to determine the differences in immune responses be-
tween Mtb-infected and uninfected HO-1+/+ and HO-1/
mice, we measured cytokine levels in the BALF. We observed
no significant differences in cytokine levels between uninfected
HO-1+/+ and HO-1/ mice. However, following infection, we
observed significantly elevated levels of IL-1b, IL-2, IL-3, IL-5,IL-6, IL-10, IL-17A, MIP-1a, MIP-1b, KC, transforming growth
factor b (TGF-b), G-CSF, and GM-CSF in HO-1/ mice
compared to HO-1+/+ (Figures 5A–5M). Notably, these cytokines
were also elevated in infected HO-1LysM/ mice compared to
the WT mice (Figures 7A–7K).
We next measured the accumulation of myeloid cells in in-
fected HO-1+/+ and HO-1/ mice. We detected no difference
in the percentage of macrophages (CD11b+Ly6C) in the BALF
or lungs fromHO-1/ and HO-1+/+ mice (data not shown). How-
ever, we did detect significant increases in the percentage of
neutrophils (CD11b+Ly6G+F4/80Gr-1) in the BALF and lungs
of HO-1/ mice compared to HO-1+/+ mice at 6, 12, and
18 weeks post-infection (Figures 5N and 5O). We also saw
increased percentages of monocytic (CD11b+Ly6C+F4/80+
Gr-1) and granulocytic (CD11b+Ly6G+F/40+Gr-1+) myeloid
cells in the lungs of Mtb-infected HO-1/ mice. At 6 weeks
post-infection, we detected no granulocytic myeloid cells; how-
ever, the percentage of monocytic cells in HO-1/ mice was
5-fold higher than in HO-1+/+ mice (Figures 5P and 5Q). Notably,
at 12 and 18 weeks post-infection, the percentage of granulo-
cytes was significantly higher in HO-1/ mice than HO-1+/+
mice and the monocyte population was no longer detectable,
indicating a more granulocytic response with disease progres-
sion (Figures 5R and 5S). We also detected significantly
increased accumulation of CD4+FoxP3+ T regulatory (T-reg)
cells in the lungs of HO-1/ mice (Figure S7D). Overall, these
data are consistent with the known role of HO-1 in regulating
myeloid cell infiltration (Hull et al., 2015; Tzima et al., 2009) and
suggest that HO-1 controls myeloid cell infiltration and the asso-
ciated inflammatory and cytokine responses to protect against
Mtb disease progression.
Mice Lacking HO-1 in Myeloid Cells Are More
Susceptible to Mtb Infection
Our findings in human TB lung tissue (Figure 3) and full-body
HO-1-deficient mice (Figure 4) suggest that homeostatic levels
of HO-1 in myeloid cells are important for tolerance against
TB. We then tested the hypothesis that HO-1 within myeloid
cells protects against Mtb infection. We used mice expressing
Cre recombinase (LysM-Cre) and biallelic floxed constructs
(referred to as HO-1LysM/) and control mice that lack
LysM-Cre construct (referred to as HO-1LysM+/+) (Hull et al.,
2015). The survival of Mtb-infected HO-1LysM/ mice was
significantly reduced compared to HO-1LysM+/+ mice (Fig-
ure 6A). Similarly, the bacterial burden in the lungs and spleens
of HO-1LysM/ mice was significantly greater at 12 and
22 weeks post-infection (Figures 6B and 6C). We measured
immune cell infiltration and observed that while the absolute
numbers of neutrophils and macrophages were not different,
the percentages of neutrophils and macrophages were
significantly higher in Mtb-infected HO-1LysM/ mice than
HO-1LysM+/+ mice (Figures 6D–6H). This increase was also
observed in uninfected mice, indicating that HO-1 expression
in myeloid cells is important in myeloid cell migration, consis-
tent with other reports (Hull et al., 2015; Tzima et al., 2009). We
also observed significantly elevated levels of IL-1a, IL-2, IL-3,
IL-5, IL-6, IL-17A, MIP-1a, MIP-1b, G-CSF, and KC in Mtb-in-
fected HO-1LysM/ mice compared to HO-1LysM+/+ miceCell Reports 25, 1938–1952, November 13, 2018 1945
Figure 5. Dysregulated Immune and Inflammatory Responses in Mtb-Infected HO-1/ Mice
(A–M) Cytokine analysis of IL-1b (A), IL-2 (B), IL-3 (C), IL-5 (D), IL-6 (E), IL-10 (F), IL-17A (G), MIP-1a (H), MIP-1b (I), KC (J), GM-CSF (K), G-CSF (L), TGF-b (M) in the
BALF of uninfected and Mtb-infected HO-1+/+ and HO-1/ mice at 6, 12, and 18 weeks.
(N and O) Percentage of neutrophils in the BALF (N) and lungs (O) of Mtb-infected HO-1+/+ and HO-1/ mice at 6, 12, and 18 weeks post-infection.
(P–S) Other monocytes and granulocytes in the lungs of Mtb-infected HO-1+/+ and HO-1/ mice.
(P and Q) Representative scatterplot for CD11b+Ly6C+F4/80+ monocytes (P) and percent differences (Q) at 6 weeks post-infection.
(R and S) Representative scatterplot for CD11b+Ly6G+F4/80+Gr-1+ granulocytes (R) and percent differences at 12 and 18 weeks post-infection (S).
n = 4 for each time point. Statistical testing was performed using the unpaired Student’s t test. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01,
***p < 0.001.(Figures 7A–7K), consistent with our findings in HO-1/ mice
(Figures 5A–5M). Together, these results strongly support our
hypothesis that HO-1 levels within myeloid cells play a key
role in limiting lethal Mtb immunopathology and control overall
Mtb disease progression.1946 Cell Reports 25, 1938–1952, November 13, 2018Myeloid HO-1 Deficiency Impairs IFN-g Production by
CD4+ T Cells during Mtb Infection
To determine the effect of myeloid-specific HO-1 deficiency on
adaptive immune responses, we measured responses in
T cells isolated from the lungs of Mtb-infected HO-1LysM/
Figure 6. Myeloid Specific HO-1 Knockout Mice (HO-1LysM/) Are Susceptible to Mtb Infection
(A) Kaplan-Meier survival analysis of Mtb-infected HO-1LysM+/+ and HO-1LysM (n = 10 mice per group).
(B and C) Bacterial burden in lungs (B) and spleens (C) of Mtb-infected HO-1LysM+/+ and HO-1LysM/ mice at 6, 12, and 24 weeks post-infection.
(D) Flow cytometry gating strategy for identification of myeloid cells.
(E and F) Absolute numbers in cells per gram of tissue (E) and proportion of CD45+ cells for lung neutrophils (F) from uninfected orMtb-infected HO-1LysM+/+ and
HO-1LysM/ mice at 12 and 24 weeks post-infection.
(G and H) Absolute numbers in cells per gram of tissue (G) and proportion of CD45+ cells for lung macrophages (H) from uninfected orMtb-infected HO-1LysM+/+
and HO-1LysM/ mice at 12 and 24 weeks post-infection.
(I) The sequential flow cytometry gating strategy for identification of IFN-g-producing lymphocytes and T cells.
(J) Representative gated population of CD45+IFN-g+ T cells.
(K and L) Differences in proportions of CD45+ cells for IFN-g+ T cells (K) and IFN-gMFI (L) isolated from the lungs ofMtb-infected HO-1LysM+/+ and HO-1LysM/
mice at 24 weeks post-infection.
(M) Representative gated population of CD45+CD4+IFN-g+ T cells.
(legend continued on next page)
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mice (Figure 6I). We first measured IFN-g production in CD45+
lymphocytes and observed that Mtb-infected HO-1LysM/
mice have significantly reduced percentages of CD45+IFN-g+
cells as well as reduced MFI of IFN-g (Figures 6J–6L). Mtb-in-
fected HO-1LysM/ mice also had increased percentages of
CD4+ T cells and significantly higher percentages of CD4+IFN-
g+-producing T cells (Figures 6M–6O). Surprisingly, the MFI of
IFN-g in CD4+ T cells was significantly lower in Mtb-infected
HO-1LysM/ mice than HO-1LysM+/+ mice (Figure 6P). Further,
Mtb-infected HO-1LysM/ mice had increased percentages of
activated (CD4+CD69+) T cells (Figures 6Q and 6R). We
observed no significant differences in the percentages of IFN-
g-producing CD4+CD69+ T cells (Figure 6S). Interestingly, the
MFI of IFN-g in activated T cells was significantly lower inMtb-in-
fected HO-1LysM/ mice than HO-1LysM+/+ mice (Figure 6T).
Together, these results indicate that HO-1 in myeloid cells mod-
ulates IFN-g production by lymphocytes during Mtb infection.
DISCUSSION
In this study, we demonstrate that HO-1 is essential for controlling
myeloid cell inflammation and associated oxidative and/or nitro-
sative stress to protect against TB immunopathology in humans.
We found that reduced levels of HO-1 result in elevated RNS
and ROS levels in myeloid cells, increased neutrophil accumula-
tion, karyorrhexis, and likely NETosis, thereby exacerbating tissue
damage in human tuberculous lungs. In support of these findings,
we employedHO-1-deficient mousemodels and found that HO-1
reduces the levels of immunomodulatory cytokines and reduces
the infiltration and accumulation of immune cells, including neu-
trophils, macrophages, and other myeloid cells. Further, the lack
of HO-1 significantly reduced IFN-g production by T cells. Overall,
this immunecontrol byHO-1 results indecreasedbacillary burden
and increased survival in mice. Our findings point to distinct path-
ological and free-radical-mediated mechanisms whereby the
temporal and spatial dysregulation of HO-1 within mouse and hu-
man lesions results in excessive inflammation and lethal immuno-
pathology. The comprehensive characterization of immune cell
types within the human TB lung represents an advance over TB
studies that rely exclusively on human blood or BALF or on animal
models that do not represent the full spectrum of human TB dis-
ease. Our findings establish a clinically relevant framework for un-
derstanding howMtb causes active TB in humans and implicates
HO-1 or its enzymatic products as potential therapeutic targets to
impede TB disease progression (Figure 7L).
The role of HO-1 in TB has been the subject of much specula-
tion. One study has shown that HO-1 is protective during myco-
bacterial infections, including Mtb (Silva-Gomes et al., 2013).(N) Differences in proportions of CD45+ cells for CD4+ T cells in the lungs of Mtb
(O and P) Differences in proportions of CD45+ cells (O) and IFN-gMFI (P) for CD4
HO-1LysM/ mice at 24 weeks post-infection.
(Q) Representative gated population of CD45+CD4+CD69+IFN-g+ T cells.
(R) Differences in proportions of CD45+ cells for CD45+CD4+CD69+ T cells in the
infection.
(S and T) Differences in proportions of CD45+ cells (S) and IFN-gMFI (T) for CD45+
and HO-1LysM/ mice at 24 weeks post-infection.
n = 4 for each time point. Statistical testing was performed using the unpaired
***p < 0.001.
1948 Cell Reports 25, 1938–1952, November 13, 2018However, a small number of mice were used in these survival
studies, and it could be argued that abnormalities associated
withwhole-bodyHO-1-deficientmice confounded theMtb infec-
tion studies. Our survival studies used a suitable number (n = 12)
ofHO-1/mice andprovide strongevidence thatHO-1 is essen-
tial for protection againstMtb infection. In addition, our myeloid-
specific knockout mice, which exhibit no signs of abnormality
(Tzima et al., 2009), were more susceptible to Mtb infection
with significantly increased bacterial burden and reduced sur-
vival. In contrast, it was reported that pharmacological inhibition
of HO-1 (Costa et al., 2016; Scharn et al., 2016) results in reduced
Mtb burden, suggesting that HO-1 promotes TB. However, we
view these findings as inconclusive, since pharmacological inhi-
bition of HO-1 had no effect on the survival ofMtb-infected mice
(Costa et al., 2016), suggesting that other factors such as HO-1-
independent T cell receptor mechanisms may be involved.
Further, the suggestion that HO-1 inhibition and a subsequent in-
crease in the localized hemeconcentration could aid in oxidative-
stress-mediated killing of Mtb overlooks the widely known fact
the heme itself can cause massive tissue damage. Indeed, pul-
monary hemorrhage (Reddy et al., 2018) and excessive hemop-
tysis, which release heme, are key features of acute human TB.
In addition, the importance of HO-1 in human health is accentu-
ated byHO-1 deficiency studies showing systemic inflammation,
red blood cell fragility, intravascular hemolysis, hemorrhage,
endothelial damage, asplenia, remarkable vulnerability to infec-
tion, high concentrations of extracellular heme, and early death
(Kawashima et al., 2002; Radhakrishnan et al., 2011). Lastly,
HO-1 deficiency in humans causes a more severe phenotype
than in mice (Kawashima et al., 2002; Yachie et al., 1999), which
is supported by the fact that unlike humans (Radhakrishnan et al.,
2011), mice fully deficient in HO-1 have a normal lifespan, albeit
with some abnormalities (Fraser et al., 2011).
Why is it necessary to examine HO-1 within the pathological
spectrum of human TB? First, it is reasonable to expect that
the spectrum correlates with the clinical, immunological, and
pathological diversity of TB (Brostoff et al., 1981; Lenzini et al.,
1977). Therefore, characterizing HO-1 within the diversity of
microanatomical niches generated by the bacillus, host, or
both, versus a single snapshot within the spectrum, will more
accurately contextualize HO-1-mediated cytoprotection during
TB. Second, as highlighted elsewhere (Cadena et al., 2017;
Kaplan et al., 2003; Kim et al., 2010), immunological variability
that contributes to a range of lesions presents the bacilli with
a choice of fuel sources that almost certainly contributes
to the dynamics of disease progression. Lastly, relating the mi-
croanatomic architecture to the underlying immune state of the
TB patient may suggest alternative therapeutic strategies and-infected HO-1LysM+/+ and HO-1LysM/ mice at 24 weeks post-infection.
5+CD4+IFN-g+ T cells isolated from the lungs ofMtb-infected HO-1LysM+/+ and
lungs of Mtb-infected HO-1LysM+/+ and HO-1LysM/ mice at 24 weeks post-
CD4+CD69+IFN-g+ T cells isolated from the lungs ofMtb-infected HO-1LysM+/+
Student’s t test. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01,
Figure 7. Cytokine Response in HO-1 LysM Mice and Proposed Model for HO-1-Mediated Protection against Mtb Infection
(A–K) Cytokine analysis (A), IL-2 (B), IL-3 (C), IL-5 (D), IL-6 (E), IL-10 (F), IL-17A (G), MIP-1a (H), MIP-1b (I), G-CSF (J), KC (K) in the BALF of uninfected andMtb-
infected HO-1LysM+/+ and HO-1LysM/mice at 6, 12, and 18 weeks post-infection. n = 4 for each time point. Statistical testing was performed using the unpaired
Student’s t test. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
(L) Proposed model for HO-1-mediated protection duringMtb infection.Mtb infection induces HO-1 expression and its downstream enzymatic cascade. Together
with its enzymatic products and ferritin, which is induced by HO-1, HO-1 protects against TB immunopathology and thereby contributes to overall TB disease
tolerance via its anti-oxidant, anti-inflammatory, and anti-proliferative properties. Therefore, maintaining the physiological levels of HO-1 is important to limit TB
disease pathology (green shaded area). Contrarily, in HO-1-deficient conditions, the levels of key pro-inflammatory cytokines are significantly elevated. This results
in rapid and dysregulatedmyeloid cell infiltration to the infected sites, which results in significantly elevated levels of ROS and RNS aswell as rapid karyorrhexis and
NETosis. ROS and RNS also generate increased localized concentrations of peroxynitrite (ONOO) and subsequent suppression of T cell responses. In addition,
Mtb infection also causes endothelial injury and intravascular coagulation, resulting in significant accumulation of heme, a potent proinflammatory and pro-oxidant
molecule. Excess heme overwhelms the cytoprotective activity of HO-1, thereby contributing pro-oxidant-mediated inflammatory responses. Together, these
dysregulated inflammatory responses result in chronic TB immunopathology and rapid disease progression (red shaded area).will provide important benchmarks for validation of animal
models of disease.
A common feature that emerged from our studies is the
spatiotemporal production of HO-1. InWT infectedmice, an initialincrease in HO-1 levels was followed by a progressive
decrease that correlates with increased mortality, pointing to the
protective role of HO-1. Similarly, our IHC and flow cytometry
data from human tuberculous lungs show that cellular distributionCell Reports 25, 1938–1952, November 13, 2018 1949
and cell type (e.g. neutrophils) and levels of HO-1 in and around
human TB lesions regulate disease progression. HO-1 is ex-
pressed within healthy cellular compartments in normal (Fig-
ure S4F) and TB-afflicted lungs (Figures 1 and 2), but the cellular
distribution and levels differ. We found that neutrophils and mac-
rophages are the predominant HO-1-producing immune cell type
in humanTB lungs.Of notewere the significantly reduced levels of
neutrophil HO-1 in the most diseased tissue, signifying a loss of
cytoprotection. These observations clearly implicate HO-1 as a
therapeutic target to improve TB disease pathology. Although in-
creases in myeloid cell infiltration have been reported in mouse
models of TB and in TB patients (du Plessis et al., 2013; Gopal
et al., 2013), the host factors regulating their migration and accu-
mulation are poorly defined. Further, the role of myeloid cells
during active TB remains unclear. Our IPA pathway analysis of
Mtb-infected HO-1/ and HO-1+/+ mice demonstrate that HO-1
is a key regulatory factor in myeloid cell migration, especially neu-
trophils, which is consistent with its role in regulating migration of
myeloid cells (Freitas et al., 2006; Hull et al., 2015). We observed
significantly elevated levels of pro-inflammatory cytokines,
including IL-6, KC, TGF-b, IL-1a, and granulocyte/monocyte col-
ony-stimulating factors such asG-CSF andGM-CSF, in the BALF
of HO-1/ mice compared to HO-1+/+ mice. These cytokines
modulatechemotaxis, induction, andmigrationofdistinctmyeloid
cells in many pathological conditions (Hammond et al., 1995;
McLoughlin et al., 2003), consistent with our IPA data (Figures
S7A–S7C). We consistently observed increased accumulation of
these myeloid cells in the lungs of both HO-1-deficient mouse
models. We also observed neutrophil accumulation in human TB
lungs (Figure S6A) as well as the co-localization of NE, MPO,
and histone H2A, suggesting the formation of NETs (Papayanno-
poulos et al., 2010). This supports other in vitro studies demon-
strating that Mtb induces NET formation and suggests a role for
NETs in human TB (Braian et al., 2013).
What are the factors that influence HO-1 cytoprotection during
TB?First,we found thatmyeloid cells in severely diseasedTB lung
tissue produce large quantities of ROS and RNS and significantly
reduced HO-1 levels. We also observed increased Arg-1 levels in
human TB lung and inMtb-infected HO/ mice. Activated mac-
rophages induce iNOS and resultant RNS and/or NO, whereas
neutrophils induce NADPH oxidase to generate ROS and/or
O2
C. These factors are major contributors to immunosuppres-
sion via induction of T-regs and inhibition of cytotoxic T lympho-
cytes, dendritic cells, and natural killer cells (Gabrilovich and
Nagaraj, 2009;Pillay et al., 2013).Neutrophilsproducesuperoxide
dismutase that converts O2
C into H2O2, which is a potent sup-
pressor of T cell functions (Bowers et al., 2014). However, the
decreased Th1 response and increased T-reg accumulation
observed in HO-1-deficient mice point to a mechanism wherein
the reduced HO-1 in myeloid cells triggers immune suppression
and tissue damage. As expected, the percentage of granulocytes
in HO-1/ mice increased during disease progression (Figures
5N–5S). Neutrophils generate high levels of O2
C and low levels
of NO, whereas macrophages generate low levels of O2
C and
high NO levels. NO reacts with O2
C to generate ONOO, a
potent suppressor of T cell function and bactericidal free radical
(Nagaraj and Gabrilovich, 2008). Hence, the ratio of granulocytes
to monocytes producing O2
C and NO, respectively, to generate1950 Cell Reports 25, 1938–1952, November 13, 2018ONOO has important pathological consequences during TBdis-
ease progression. Second, it is well established that oxidative
stress can trigger karyorrhexis (Korolczuk et al., 2016), a process
that overlaps with apoptosis and NETosis that we observed in the
human tuberculous lung (Figures S6A and S6B). Not surprisingly,
large numbers of karyorrhectic, degenerate neutrophils were
observed in cavitary lesions and around caseative suppurative
granulomatous lesions, which upon HO-1 staining produced a
clearly defined zonal or graded HO-1 pattern (Figures 1, 2, S2A,
S4D,andS4E). Third, consistentwithpreviousstudiesandourhis-
topathological analyses, we observed substantial hemorrhagic
inflammation (FiguresS6C,S1A,andS1B), resulting fromruptured
alveolar walls and the release of large quantities of erythrocyte-
derived heme (Canetti, 1955). As previously reported, excess
heme and release of iron (Reddy et al., 2018) may overwhelm
the cytoprotective capacity of HO-1 by rapid recruitment of neu-
trophils, oxidative and inflammatory imbalance, and vascular
dysfunction (Jeney et al., 2002;Wagener et al., 2001). This patho-
physiological response may be exacerbated by the decreased
HO-1 levels we observed in human TB lung tissue and in animal
studies at the late stages of infection. Therefore, it is not surprising
that fluctuations in HO-1 levels in TB foci lead to dysregulated im-
mune responses.Overall, our findings suggest that reducedHO-1
levels lead to increasedmigration and accumulation of inflamma-
torymyeloid cells, including neutrophils, which leads to increased
ROS, RNS, and Arg-1 levels. In turn, this uncontrolled inflamma-
tion results in immunosuppression and disease pathology.
Apotential limitationof our humanstudies is that lung tissuewas
sourced from TB patients with different medical histories and
treatments. Indeed, this may be reflected in the inconsistent
macrophage population observed in some of the human lung tis-
sues. However, the statistically significant differences in HO-1
levels, ROS, and RNS in neutrophils, macrophages, and mono-
cytes isolated from diseased, intermediate, and uninvolved lung
tissues, albeit from different patients, highlight the critical role of
HO-1 inmediating the inflammatory response inhumanTB.Lastly,
it is likely that a larger test cohort may render a wider and more
divergent disease spectrum, which is the goal of ongoing studies.
In conclusion, our data demonstrate that HO-1 expression in
myeloid cells is crucial for host defense to limit immunopa-
thology and disease progression during Mtb infection. The
evidence shows that zonal HO-1 distributionwithin the TBmicro-
environment regulates the accumulation and inflammatory re-
sponses of myeloid cells. These responses include RNS- and
ROS-mediated stress, karyorrhexis, NETosis, and intravascular
hemorrhage, which overall dictate the TB immunopathology.
Lastly, these findings suggest that pharmacological upregulation
of cytoprotective HO-1 activity may limit immunopathology dur-
ing active TB disease.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human Subjects
The study was approved by the University of KwaZulu-Natal Biomedical Research Ethics Committee (Class approval study number
BCA 535/16). Patients undergoing lung resection for TB (Study ID: BE 019/13) were recruited fromKing DinuZulu Hospital Complex, a
tertiary center for TB patients in Durban, South Africa. In Durban, South Africa, Mtb-infected human lung tissues are routinely ob-
tained following surgery for removal of irreversibly damaged lobes or lungs (bronchiectasis and/or cavitary lung disease). Written
informed consent was obtained from all participants. All patients undergoing lung resection for TB had completed a full 6-9-month
course of anti-TB treatment, or up to 2 years of treatment for drug-resistant TB. Patients were assessed for extent of pulmonary dis-
ease (cavitation and or bronchiectasis) via high-resolution computed tomography. The fitness to withstand a thoracotomy and lung
resection of each patient was determined by Karnofsky score, six-minute walk test, spirometry and arterial blood gas. Assessment of
patients with massive hemoptysis included their general condition, effort tolerance prior to hemoptysis, arterial blood gas measure-
ment, serum albumin level and an HRCT of the chest. Pneumonectomy specimens that were excised for pulmonary TB showed cav-
itational disease and tubercles and were selected for assessment. On gross assessment all pneumonectomies were bronchiectatic,
hemorrhagic, variably fibrotic and atelectatic and contained tubercles that measured 2-5 mm in size. One specimen demonstrated a
tuberculous cavity; Aspergillomas were not present. Please refer to the Table S1 for specific details on each patient.e2 Cell Reports 25, 1938–1952.e1–e5, November 13, 2018
Animals
Global HO-1–deficient mice (HO-1/) on a C57BL/63 FVB background and their HO-1+/+ (wild-type) littermates (Hull et al., 2015;
Poss and Tonegawa, 1997) andmyeloid-specific HO-1/mice (referred to as HO-1LysM/) and HO-1 flox mice on C57BL/6 that
lack the LysM-Cre construct (HO-1LysM+/+) (Hull et al., 2015; Jais et al., 2014) were used in the study. Age-matched mice
(8-12 weeks old) were housed under animal BSL-3 conditions following Mtb H37Rv infection and monitored daily. All the animals
weremaintained in pathogen free facility and animal maintenance and all procedures followed protocols approved by the Institutional
Animal Care and Use Committee of the University of Alabama at Birmingham.
Bacterial Strains
For animal infection studies,Mycobacterium tuberculosis H37Rv was used as descried (Reddy et al., 2018).Mtb was grown at 37C
with shaking in BD Difco Middlebrook (MB) 7H9 (broth) or standing on MB7H11 (agar) media supplemented with 0.2% glycerol, ADS
(Albumin, Dextrose, NaCl) with 0.02% tyloxapol.
METHOD DETAILS
Infection of Mice
Mtb H37Rv was grown to mid-log phase in Middlebrook 7H9 liquid medium (Difco, Detroit, MI, USA) containing 0.2% glycerol, and
0.02% Tyloxapol supplemented with ADS (Albumin, Dextrose, Saline). Cells were washed and re-suspended in PBS containing
0.02% Tyloxapol to give a final inoculum of 5x104 CFU in 50 ml. Mice received intratracheal instillation of 50ml of inoculum or
PBS. Animals were observed for survival (n = 10) or sacrificed at the indicated time points (n = 4 per time point). Bronchoalveolar
lavage (BAL) fluid and lung leukocyte infiltrates were isolated in sterile PBS as described previously (16). For microarray, calculation
of bacillary burden, cytokine analysis, histopathological and flow cytometric analysis of lung tissue were performed as described
below.
Microarray and Pathway Analysis
Blood monocytes were isolated from mice infected with Mtb H37Rv. Total RNA was harvested 24 hours post-infection for cDNA
preparation using QIAGEN protocols and reagents. cDNA was prepared using protocols recommended by Affymetrix and reagents
obtained from Invitrogen. Biotin labeled-cRNA preparation was done using protocols and reagents from Affymetrix. The labeled-
cRNA hybridized to AffymetrixMouse Genome 430 2.0 GeneChip arrays (Cat. # 900497). Pathway analysis was done using Inge-
nuity Pathways Analysis (IPA). The results were ordered by -log10 of the p value of the hypergeometric distribution.
Determination of Bacterial Burden
To determine the number of viable Mtb in the lung and spleen of infected mice, organs were removed aseptically at specified time
points. Part of the tissue was homogenized in 0.02% Tween-80/PBS. Viable Mtb were determined as CFU by performing serial di-
lutions of the tissue homogenates in PBS and plating onto Middlebrook 7H11 agar plates (Difco Laboratories, Detroit, MI, USA) sup-
plemented with ADS (Albumin, dextrose, and saline) and 50 mg each of Carbenicillin and Cycloheximide antibiotics (Sigma-Aldrich,
St. Louis, MO, USA). The plates were incubated at 37C and colonies were counted after 3-4 weeks. The plates were further incu-
bated for an additional 2 weeks to ensure detection of slower growingMtb. The number of CFU is expressed as cfu per lung/spleen
from four individual mice for each time point.
Isolation of BAL fluid and Cytokine ELISA
After euthanizing animal, tracheawas exposed and a Safelet Cath (22 g3 100, Exel) was inserted into the trachea and 1mL of PBSwas
instilled and aspirated. The lavage samples were centrifuged at 2,5003 g for 5 min at 4C to pellet the cells and the supernatant was
stored until further analysis. Cytokine levels were determined using Bio-Plex ProTM Mouse Cytokine 23-Plex, Group-1 (BIO-RAD,
Hercules, CA). Individual cytokine concentrations were measured and expressed in pg/ml as per manufacturer instructions.
Western Blotting
Mtb-infected mouse lungs were lysed in RIPA buffer containing protease inhibitors (cOmplete Tablets, Roche) using a dounce
homogenizer. Protein was quantified using the BCA protein assay kit (Thermo Scientific). 20 mg of total protein was resolved on a
4%–15% gradient SDS-PAGE gel (Bio-Rad) and transferred to a PVDF membrane. Membranes were blocked in 5% nonfat dry
milk in PBS-T for 1 hr and then incubated with a primary antibody for HO-1 (ADI-SPA-895-F, Enzo Life Sciences, Farmingdale,
NY) and Nrf-2 (SC-722, Santa Cruz Biotechnology, Dallas, TX.) followed by a peroxidase conjugated secondary antibody
(ab6721, Abcam, Cambridge, MA). HRP activity was detected using ECL Western Blotting reagent (Amersham).
RNA extraction and real-time PCR from lung tissues
Total RNA from lungs ofMtb-infected HO-1+/+ and HO-1/mice was extracted using RNeasy Plus mini kit as per manufacturers
recommendations (QIAGEN). Genomic DNAwas removed by treatment of RNA samples with RNase-free DNase I (Thermo Scientific)
for 15 min at RT followed by 30 min at 37C. One microgram of total RNA was used to generate cDNA by using the iScript cDNACell Reports 25, 1938–1952.e1–e5, November 13, 2018 e3
synthesis Kit (Bio-Rad). Quantitative real-time PCRwas performed using SSO Advanced SYBRGreen Supermix (Bio-Rad). The rela-
tive gene expression was normalized to mouse GAPDH as an internal control.
Mouse Histopathology
Histological sections were stained with H&E or trichrome stain for evaluation of pathology and fibrosis, respectively. Briefly, samples
of lung and spleen were aseptically removed and fixed in 10%buffered formalin and embedded in paraffin. Five-micrometer sections
were stained with hematoxylin-eosin or the Masson trichrome method using standard procedures
Flow Cytometry of Mice Immune Cell Isolates
Immune cells were isolated from lung tissue as described (16), in a BSL-3 facility using BSL-3 practices and procedures. Briefly, to
reduce contamination of isolated lung cells with blood, the pulmonary circulation was perfused with PBS via the right ventricle
following euthanasia and thoracotomy. Airway lavage was performed three times with 0.8 mL of PBS each. Infiltrating leukocytes
were isolated fromminced lung tissue by treatment with collagenase-B (2mg/ml, Roche) andDNase I (0.02mg/ml, Sigma) in Iscove’s
modified Dulbecco’s medium (IMDM) supplemented with 1 mM sodium pyruvate, 2 mM L-glutamine, 10 mg/ml penicillin-strepto-
mycin, 25 mM 2-mercaptoethanol and 0.1 mM non-essential amino acids (Life Technologies) at 37OC for 30 min. This was followed
by the addition of an equal volume of IMDM containing 20% FBS. Cell suspensions were filtered using 40-mm cell strainer, washed
with PBS, counted and fixed with buffered formalin. After fixation, the cells were washed in PBS and pretreated at 4C for 20 minutes
in FACS staining buffer (PBS + 3% FBS) containing 2.0 mg/ml of the mAb 2.4G2 to block Fc-mediated binding of subsequent anti-
bodies (BD PharMingen, Franklin Lakes, NJ). These cells were then stained to identify and characterize immune cell populations us-
ing fluorescence conjugated antibodies directed against the cell surface markers for 30 min at 4C (all antibodies were purchased
from eBioscience, San Diego, CA). For detecting the frequency of IFN-g-secreting cells, cells were cultured in RPMI-1640 containing
5 ng/ml PMA and 500 ng/ml Ionomycin along with 10 mg/ml GolgiPlug protein transport inhibitor (BD Biosciences, Sparks, MD), at
37C for 3 hours. Cells were then harvested, fixed with buffered formalin and permeabilized using a BD cytofix/cytoperm fixation/
permeabilization kit (BD Biosciences) and then stained with FITC-labeled 53-6.7 antibody directed against IFN-g. Cells were washed
twice with PBS before analysis. Flow cytometry acquisitions and analyses were carried out using Becton Dickinson LSR II with FACS
Diva software (BD Biosciences, San Jose, CA). Data were further analyzed using FlowJo 10 (Tree Star, Ashland, OR).
Human Lung Cell Isolation and Flow Cytometry
Lung tissue was washed with HBSS to remove excess blood and cut into small sections approximately 0.5 mm thick with a sterile
scalpel. The sections were washed 3 times with RPMI 1640 medium containing 10% fetal calf serum. To isolate interstitial cells, lung
sections were digested with 0.5 mg/ml type collagenase D (Sigma) and 40 units/ml DNAase I (Roche). Tissue was then mechanically
dissociated using the GentleMacs system (lung program,Miltenyi) at 37C for 60minutes followed by a second round of dissociation.
Cells were then washed twice in medium, strained through a 70 mM cell strainer. Isolated lung cells were surface stained with mAbs
directed against CD14 (M5E2; BD Biosci.), CD66b (G10F5, BD Biosci.), CD45 (HI10; BD Biosci.), CD16 (3G8; BD Biosci.), CD206
(19.2; BD Biosci.) at 4C for 30 minutes followed by two washes with PBS. To detect intracellular HO-1 and iNOS levels, the surface
labeled cells were fixed and permeabilized (Cytofix/CytoPerm, BD) and stained with FITC labeled conjugated HO-1 (HO-1; Enzo) or
anti-iNOS (Novous Biologicals) at 4C for 30 min followed by two washes with PBS. For ROI/RNI detection, following cell surface
labeling, cells were washed and stained either with 25 mMDHE or 25 mMDAF-FM (Life technologies) at 37C for 30 minutes followed
by two PBSwashes. Data acquisition was performed on a BD Biosciences Fortessa flow cytometer and analysis was performed with
Flowjo Vx.0.7.
Human Lung Tissue Immunohistochemistry
Human lung tissues were cut into 2 mm thick sections were mounted on charged slides and heated at 56C for 15 min. Mounted sec-
tions were dewaxed in xylene followed by rinse in 100% ethanol and 1 change of SVR (95%). Slides were then washed under running
water for 2 min followed by antigen retrieval via Heat Induced Epitope Retrieval (HIER) in Tris-sodium chloride (pH 6.0) for 30 min.
Slides were then cooled for 15 min and rinsed under running water for 2 min. Endogenous peroxide activity was blocked using
3% hydrogen peroxide for 10 min at room temperature (RT). Slides were then washed in PBST and blocked with protein block
(Novolink) for 5 min at RT. Sections were incubated with primary antibodies for HO-1 (ab13248, Abcam; 1:100 dilution), Nrf-2 (sc-
722, Santa Cruz Biotechnology, 1:100), Arg-1 (sc-20150, Santa Cruz Biotechnology, Inc., 1:100 dilution), NOS2 (sc-651, Santa
Cruz Biotechnology, 1:100 dilution), MPO heavy chain (sc-34161, SantaCruz Biotechnology, 1:100), Histone H2A.X (sc-54607,
SantaCruZ Biotechnology, 1:100) and Neutrophil elastase (sc9521, SantaCruz Biotechnology) followed by washing and incubation
with either HRP anti-rabbit IgG HRP (ab6721, abcam), anti-Goat IgG (H+L)-Alexa Fluor 555 or the polymer (Novolink) for 30min at RT.
Slides were thenwashed and stainedwith DAB for 5min, washed under runningwater and counterstainedwith hematoxylin for 2min.
Slides were rinsed under running water, blued in 3% ammoniated water for 30 s, washed under water, dehydrated and mounted in
Distyrene Plasticiser Xylene (DPX). For isotype control sections, a similar protocol was followed and either IgG4 (LS-C70325/27332)
or rabbit IgG (ab37415, Abcam) was used (at the same concentration/dilution as the primary antibodies) in place of the primary an-
tibodies (isotype control). For neutrophil staining, after secondary staining, slides were washed, dehydrated and mounted using
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Pathology images were captured at 10x magnification on a Hamamatsu NanoZoomer 2.0RS slide scanner. The resulting image files
were converted to JPEG format (lossless compression) with NDPItools (https://www.imnc.in2p3.fr/pagesperso/deroulers/software/
ndpitools/) for further analysis. Background over-staining was subsequently removed in in FIJI (FIJI Is Just ImageJ) using the Subtract
Background plugin (settings: rolling ball radius of 50 pixels, light background, separate colors). Following that, deconvolution was
performed in using the Color Deconvolution plugin FIJI (using custom trained vectors for H-DAB staining) (Schindelin et al., 2012).
Anaconda/Python scripts calling the numpy, scipy, skimage, pandas, seaborn and matplotlib libraries were used for further analysis.
A sliding window of 10001 and 1001 pixels (necrotic lesions and NNGI granulomas respectively) was used to calculate running av-
erages for DAB stain intensity projected on the major axis (normalized to 1.0) of a rectangular region traversing each granuloma,
lesion or appropriate control region. The same size rectangular region was used for each necrotic lesion and granuloma, respectively.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were performed using unpaired, two tailed Student’s t test and the data were expressed as mean ± SEM, unless
indicated, using GraphPad Prism 6 (GraphPad Software, Inc., La Jolla, USA). Statistical significance was defined as: *p < 0.05,
**p < 0.01, ***p < 0.001. Statistical test, method of error calculation and significance for each figure can be found in the respective
figure legend.
DATA AND SOFTWARE AVAILABILITY
The accession number for the raw and processed microarray data reported in this paper is ArrayExpress: E-MTAB-7221 (www.ebi.
ac.uk/arrayexpress).
High resolution immunostaining figures will be provided upon request or can be downloaded at: https://www.ahri.org/scientist/
adrie-steyn/ (Accessed: January 1, 2019). Please contact Dr. Adrie J.C. Steyn (adrie.steyn@ahri.org or asteyn@uab.edu).Cell Reports 25, 1938–1952.e1–e5, November 13, 2018 e5
